window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 20, 2026

  • News
  • About Us
Contact Us

European biotech

  • Biotech,Clinical Development,Drug Development,European biotech,Hematology,Research & Development,Respiratory

    Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk

    Cereno Scientific has published the first peer-reviewed paper describing its [...]

    January 16, 2026
  • Clinical Trials,Dermatology,Drug Development,European biotech,Pharmaceuticals and therapeutics

    Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema

    Almirall has announced plans to initiate a phase 3 clinical [...]

    January 15, 2026
  • European biotech,Partnerships & Funding,Research & Development,Technology and platforms

    Novo Nordisk Foundation commits DKK 5.5BN (EUR 736M) to BioInnovation Institute expansion

    The Novo Nordisk Foundation has committed up to DKK 5.5 [...]

    January 14, 2026
  • Artificial Intelligence,Drug Development,European biotech,Partnerships & Funding,Technology and platforms

    FluoSphera raises €1.23 million to scale human-based preclinical testing platform

    Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]

    January 12, 2026
  • Biotech,Central Nervous System,Clinical Development,European biotech,Regulatory Affairs

    Single-cell analysis highlights molecular subgroups in endometriosis that could inform clinical trials

    Endometriosis is typically treated as a single condition, yet patients [...]

    January 7, 2026
  • Biotech,Central Nervous System,Clinical Development,European biotech,Regulatory Affairs

    Newron expands evenamide IP protection with new EU composition of matter patent

    Newron has expanded the intellectual property protection for its lead [...]

    January 6, 2026
  • Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,European biotech,Partnerships & Funding

    eXmoor and UCL partner to accelerate academic cell and gene therapy programmes

    eXmoor Pharma has formed a strategic collaboration with University College [...]

    December 3, 2025
  • Biotech,Clinical Development,Drug Development,European biotech,Movers & Shakers,Oncology,Research & Development

    Mosaic Therapeutics appoints Stephen Shuttleworth as chief scientific officer

    Mosaic Therapeutics has appointed Stephen Shuttleworth as chief scientific officer [...]

    November 20, 2025
  • Biotech,Clinical Development,Drug Development,European biotech,Movers & Shakers,Oncology

    Ona Therapeutics appoints Antoine Yver as chair to steer ADC pipeline into clinical development

    Ona Therapeutics has appointed Antoine Yver as chair of its [...]

    November 19, 2025
  • Clinical Development,European biotech,Facilities and infrastructure,Market Access & Commercialization

    Ono opens new Zug office to support European expansion

    Ono has opened a new office in Zug to strengthen [...]

    November 17, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk
    Categories: Biotech, Clinical Development, Drug Development, European biotech, Hematology, Research & Development, Respiratory
  • SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform
    Categories: Data Management, Genomics and sequencing, Research & Development, Technology and platforms
  • Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema
    Categories: Clinical Trials, Dermatology, Drug Development, European biotech, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top